JP2009529498A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009529498A5 JP2009529498A5 JP2008556626A JP2008556626A JP2009529498A5 JP 2009529498 A5 JP2009529498 A5 JP 2009529498A5 JP 2008556626 A JP2008556626 A JP 2008556626A JP 2008556626 A JP2008556626 A JP 2008556626A JP 2009529498 A5 JP2009529498 A5 JP 2009529498A5
- Authority
- JP
- Japan
- Prior art keywords
- sod1
- antibody
- seq
- substance
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000008221 Superoxide Dismutase-1 Human genes 0.000 claims 40
- 108010021188 Superoxide Dismutase-1 Proteins 0.000 claims 40
- 239000000126 substance Substances 0.000 claims 36
- 108090000765 processed proteins & peptides Proteins 0.000 claims 22
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 20
- 230000002163 immunogen Effects 0.000 claims 18
- 239000008194 pharmaceutical composition Substances 0.000 claims 17
- 201000010099 disease Diseases 0.000 claims 11
- 239000000178 monomer Substances 0.000 claims 11
- 239000000539 dimer Substances 0.000 claims 9
- 208000035475 disorder Diseases 0.000 claims 9
- 238000000034 method Methods 0.000 claims 9
- 150000007523 nucleic acids Chemical group 0.000 claims 6
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 5
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims 5
- 210000004408 hybridoma Anatomy 0.000 claims 5
- 230000001404 mediated effect Effects 0.000 claims 5
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims 4
- 239000000427 antigen Substances 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 208000024827 Alzheimer disease Diseases 0.000 claims 3
- 102000019197 Superoxide Dismutase Human genes 0.000 claims 3
- 108010012715 Superoxide dismutase Proteins 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 2
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 2
- 208000018737 Parkinson disease Diseases 0.000 claims 2
- 230000003053 immunization Effects 0.000 claims 2
- 230000000626 neurodegenerative effect Effects 0.000 claims 2
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 208000009829 Lewy Body Disease Diseases 0.000 claims 1
- 201000002832 Lewy body dementia Diseases 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000002872 contrast media Substances 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 238000012631 diagnostic technique Methods 0.000 claims 1
- 239000007850 fluorescent dye Substances 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 230000005847 immunogenicity Effects 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 108010045069 keyhole-limpet hemocyanin Proteins 0.000 claims 1
- 229910021645 metal ion Inorganic materials 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77837906P | 2006-03-03 | 2006-03-03 | |
| US11/367,609 | 2006-03-03 | ||
| US60/778,379 | 2006-03-03 | ||
| US11/367,609 US7439324B2 (en) | 2003-08-20 | 2006-03-03 | ALS-specific peptide composition |
| US79872806P | 2006-05-09 | 2006-05-09 | |
| US79872706P | 2006-05-09 | 2006-05-09 | |
| US60/798,727 | 2006-05-09 | ||
| US60/798,728 | 2006-05-09 | ||
| US11/565,967 US7794692B2 (en) | 2005-12-02 | 2006-12-01 | Methods and compositions for detecting amyotrophic lateral sclerosis |
| US11/565,967 | 2006-12-01 | ||
| PCT/CA2007/000346 WO2007098607A1 (en) | 2006-03-03 | 2007-03-05 | Methods and compositions to treat and detect misfolded-sod1 mediated diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012275632A Division JP2013091648A (ja) | 2006-03-03 | 2012-12-18 | ミスフォールドｓｏｄ１媒介疾患を処置および検出するための方法および組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009529498A JP2009529498A (ja) | 2009-08-20 |
| JP2009529498A5 true JP2009529498A5 (https=) | 2010-04-22 |
| JP5823663B2 JP5823663B2 (ja) | 2015-11-25 |
Family
ID=38460601
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008556626A Expired - Fee Related JP5823663B2 (ja) | 2006-03-03 | 2007-03-05 | ミスフォールドｓｏｄ１媒介疾患を処置および検出するための方法および組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US7977314B2 (https=) |
| EP (5) | EP1989308B1 (https=) |
| JP (1) | JP5823663B2 (https=) |
| AU (1) | AU2007219615B2 (https=) |
| CA (1) | CA2642848C (https=) |
| DK (2) | DK2495327T3 (https=) |
| WO (1) | WO2007098607A1 (https=) |
Families Citing this family (72)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10303974A1 (de) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
| EP1668369B1 (en) | 2003-08-20 | 2016-01-06 | ProMIS Neurosciences Inc. | Epitope protection assay and method for detecting protein conformations |
| US9050005B2 (en) | 2005-08-25 | 2015-06-09 | Synapse Biomedical, Inc. | Method and apparatus for transgastric neurostimulation |
| HRP20140240T4 (hr) | 2005-11-30 | 2017-02-24 | Abbvie Inc. | Monoklonalna antitijela protiv amiloidnih beta proteina i njihova upotreba |
| US8691224B2 (en) | 2005-11-30 | 2014-04-08 | Abbvie Inc. | Anti-Aβ globulomer 5F7 antibodies |
| US7887803B2 (en) | 2005-12-02 | 2011-02-15 | Amorfix Life Sciences | Methods and compositions to treat misfolded-SOD1 mediated diseases |
| US7794692B2 (en) | 2005-12-02 | 2010-09-14 | Amorfix Life Sciences Ltd. | Methods and compositions for detecting amyotrophic lateral sclerosis |
| US7977314B2 (en) | 2005-12-02 | 2011-07-12 | Amorfix Life Sciences Limited | Methods and compositions to treat and detect misfolded-SOD1 mediated diseases |
| EP1996284A2 (en) | 2006-03-09 | 2008-12-03 | Synapse Biomedical, Inc. | Ventilatory assist system and method to improve respiratory function |
| EP2029722B1 (en) | 2006-05-22 | 2019-10-16 | Biovest International, Inc. | Method and system for the production of cells |
| US20080097153A1 (en) * | 2006-08-24 | 2008-04-24 | Ignagni Anthony R | Method and apparatus for grasping an abdominal wall |
| US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
| US9079016B2 (en) | 2007-02-05 | 2015-07-14 | Synapse Biomedical, Inc. | Removable intramuscular electrode |
| US8895004B2 (en) | 2007-02-27 | 2014-11-25 | AbbVie Deutschland GmbH & Co. KG | Method for the treatment of amyloidoses |
| WO2008144578A1 (en) | 2007-05-17 | 2008-11-27 | Synapse Biomedical, Inc. | Devices and methods for assessing motor point electromyogram as a biomarker |
| US8478412B2 (en) | 2007-10-30 | 2013-07-02 | Synapse Biomedical, Inc. | Method of improving sleep disordered breathing |
| US8428726B2 (en) | 2007-10-30 | 2013-04-23 | Synapse Biomedical, Inc. | Device and method of neuromodulation to effect a functionally restorative adaption of the neuromuscular system |
| US9217155B2 (en) | 2008-05-28 | 2015-12-22 | University Of Massachusetts | Isolation of novel AAV'S and uses thereof |
| AU2009301580B2 (en) * | 2008-10-06 | 2015-11-26 | The University Of British Columbia | Methods and systems for predicting misfolded protein epitopes |
| US8734809B2 (en) | 2009-05-28 | 2014-05-27 | University Of Massachusetts | AAV's and uses thereof |
| WO2011074690A1 (en) * | 2009-12-14 | 2011-06-23 | Kyoto University | Pharmaceutical composition for prevention and treatment of amyotrophic lateral sclerosis |
| US8987419B2 (en) | 2010-04-15 | 2015-03-24 | AbbVie Deutschland GmbH & Co. KG | Amyloid-beta binding proteins |
| US9546369B2 (en) | 2010-04-23 | 2017-01-17 | University Of Massachusetts | Multicistronic expression constructs |
| EP3444346B1 (en) | 2010-04-23 | 2022-07-27 | University of Massachusetts | Aav-based treatment of cholesterol-related disorders |
| EP2561073B1 (en) | 2010-04-23 | 2016-08-24 | University of Massachusetts | Cns targeting aav vectors and methods of use thereof |
| EP3533803B1 (en) | 2010-08-14 | 2021-10-27 | AbbVie Inc. | Anti-amyloid-beta antibodies |
| WO2012058220A2 (en) | 2010-10-26 | 2012-05-03 | University Of Massachusetts | Anti-sod1 antibodies and uses thereof |
| US20120328605A1 (en) * | 2010-10-27 | 2012-12-27 | Daniel Larocque | Compositions and uses |
| AU2011343161B2 (en) * | 2010-12-17 | 2017-02-02 | Neurimmune Holding Ag | Human anti-SOD1 antibodies |
| WO2012171030A2 (en) | 2011-06-10 | 2012-12-13 | Biovest International, Inc. | Method and apparatus for antibody production and purification |
| EP2909302A4 (en) | 2012-08-28 | 2016-07-27 | Biovest Int Inc | BIOFABRICATION FILAMENT AND METHOD FOR LARGE-SCALE PRODUCTION OF CELLS, VIRUSES AND BIOMOLECULES |
| ES2673583T3 (es) * | 2013-02-28 | 2018-06-22 | National Cancer Center | Anticuerpo contra fibrina insoluble |
| GB2514407A (en) * | 2013-05-23 | 2014-11-26 | Stefan L Marklund | Aggregates of superoxide dismutase |
| EP3004170A1 (en) * | 2013-05-28 | 2016-04-13 | VIB vzw | Single domain antibodies against sod1 and their use in medicine |
| CA2942515C (en) | 2014-03-18 | 2025-12-09 | University Of Massachusetts | Raav-based compositions and methods for treating amyotrophic lateral sclerosis |
| WO2015164786A1 (en) | 2014-04-25 | 2015-10-29 | University Of Massachusetts | Recombinant aav vectors useful for reducing immunity against transgene products |
| WO2015187825A2 (en) | 2014-06-03 | 2015-12-10 | University Of Massachusetts | Compositions and methods for modulating dysferlin expression |
| US10370432B2 (en) | 2014-10-03 | 2019-08-06 | University Of Massachusetts | Heterologous targeting peptide grafted AAVS |
| CN107073051B (zh) | 2014-10-21 | 2021-08-24 | 马萨诸塞大学 | 重组aav变体及其用途 |
| WO2016077687A1 (en) | 2014-11-14 | 2016-05-19 | Voyager Therapeutics, Inc. | Compositions and methods of treating amyotrophic lateral sclerosis (als) |
| US9879080B2 (en) | 2015-01-28 | 2018-01-30 | Prothena Biosciences Limited | Anti-transthyretin antibodies |
| US10464999B2 (en) | 2015-01-28 | 2019-11-05 | Prothena Biosciences Limited | Anti-transthyretin antibodies |
| US10633433B2 (en) | 2015-01-28 | 2020-04-28 | Prothena Biosciences Limited | Anti-transthyretin antibodies |
| EP3256170B1 (en) | 2015-02-13 | 2020-09-23 | University of Massachusetts | Compositions and methods for transient delivery of nucleases |
| US11046955B2 (en) | 2015-04-24 | 2021-06-29 | University Of Massachusetts | Modified AAV constructs and uses thereof |
| WO2017115367A1 (en) | 2015-12-28 | 2017-07-06 | The National Institute for Biotechnology in the Negev Ltd. | Composition and method for treating amyotrophic lateral sclerosis |
| CA3011939A1 (en) | 2016-02-02 | 2017-08-10 | University Of Massachusetts | Method to enhance the efficiency of systemic aav gene delivery to the central nervous system |
| CA3012344A1 (en) | 2016-02-12 | 2017-08-17 | University Of Massachusetts | Anti-angiogenic mirna therapeutics for inhibiting corneal neovascularization |
| US11001893B2 (en) | 2016-06-10 | 2021-05-11 | Zinfandel Pharmaceuticals, Inc. | Methods for detecting structural variants in neurodegenerative disease |
| US10457940B2 (en) | 2016-09-22 | 2019-10-29 | University Of Massachusetts | AAV treatment of Huntington's disease |
| AU2017341849B2 (en) | 2016-10-13 | 2024-03-21 | University Of Massachusetts | AAV capsid designs |
| JP2020518258A (ja) | 2017-05-05 | 2020-06-25 | ボイジャー セラピューティクス インコーポレイテッドＶｏｙａｇｅｒ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | 筋萎縮性側索硬化症（ａｌｓ）治療組成物および方法 |
| US11859179B2 (en) | 2017-05-09 | 2024-01-02 | University Of Massachusetts | Methods of treating amyotrophic lateral sclerosis (ALS) |
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| CN111448321A (zh) | 2017-09-22 | 2020-07-24 | 马萨诸塞大学 | Sod1双表达载体及其用途 |
| AU2018345807B2 (en) | 2017-10-06 | 2025-02-06 | Novo Nordisk A/S | Methods of detecting transthyretin |
| CU24731B1 (es) | 2017-10-06 | 2025-01-15 | Prothena Biosciences Ltd | Anticuerpos anti-transtiretina |
| EP3697908A1 (en) | 2017-10-16 | 2020-08-26 | Voyager Therapeutics, Inc. | Treatment of amyotrophic lateral sclerosis (als) |
| TW202413649A (zh) | 2017-10-16 | 2024-04-01 | 美商航海家醫療公司 | 肌萎縮性脊髓側索硬化症(als)之治療 |
| CN111787942B (zh) | 2017-10-25 | 2024-03-29 | 杨森制药公司 | 磷酸化Tau肽的组合物及其用途 |
| PE20211453A1 (es) | 2017-11-29 | 2021-08-05 | Prothena Biosciences Ltd | Formulacion liofilizada de un anticuerpo monoclonal contra transtirretina |
| WO2019236995A1 (en) | 2018-06-08 | 2019-12-12 | University Of Massachusetts | Antisense oligonucleotides to restore dysferlin protein expression in dysferlinopathy patient cells |
| US20210254103A1 (en) | 2018-07-02 | 2021-08-19 | Voyager Therapeutics, Inc. | Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cord |
| CN121248772A (zh) | 2018-08-17 | 2026-01-02 | Ab工作室有限公司 | 催化抗体和其使用方法 |
| US11471683B2 (en) | 2019-01-29 | 2022-10-18 | Synapse Biomedical, Inc. | Systems and methods for treating sleep apnea using neuromodulation |
| WO2020160156A2 (en) | 2019-01-30 | 2020-08-06 | Immutics, Inc. | Anti-gal3 antibodies and uses thereof |
| MY206596A (en) | 2019-02-08 | 2024-12-25 | Janssen Pharmaceuticals Inc | Method of safe administration of phosphorylated tau peptide vaccine |
| EP4121766A1 (en) * | 2020-03-18 | 2023-01-25 | AL-S Pharma AG | Misfolded sod1 assay |
| EP4157338A4 (en) | 2020-05-26 | 2024-11-13 | TrueBinding, Inc. | METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING |
| JP7376203B2 (ja) * | 2021-08-18 | 2023-11-08 | 株式会社 バイオラジカル研究所 | 身体的フレイルの試験方法、身体的フレイルの試験試薬、身体的フレイルの治療薬候補物質のスクリーニング方法、精神的フレイルの試験方法、精神的フレイルの試験試薬、および精神的フレイルの治療薬候補物質のスクリーニング方法 |
| JPWO2023033050A1 (https=) * | 2021-09-02 | 2023-03-09 | ||
| WO2024226761A2 (en) | 2023-04-26 | 2024-10-31 | Voyager Therapeutics, Inc. | Compositions and methods for treating amyotrophic lateral sclerosis |
Family Cites Families (92)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4910133A (en) * | 1985-08-29 | 1990-03-20 | Ube Industries, Limited | Diagnostic test drug comprising monoclonal antibody to human copper.zinc-superoxide dismutase and diagnostic test method using the same |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US4902505A (en) | 1986-07-30 | 1990-02-20 | Alkermes | Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
| US4940659A (en) * | 1987-02-20 | 1990-07-10 | Monoclonetics International, Inc. | Screening extra-cellular body fluids for superoxide dismutase (SOD-1) for determining fetal trisomy 21 down syndrome |
| CA1331443C (en) | 1987-05-29 | 1994-08-16 | Charlotte A. Kensil | Saponin adjuvant |
| US4806627A (en) * | 1987-05-29 | 1989-02-21 | Research Foundation Of Mental Hygiene Inc. | Hybrid cell lines producing monoclonal antibodies dircted against scrapie-associated fibril proteins |
| US5672344A (en) | 1987-12-30 | 1997-09-30 | The Regents Of The University Of Michigan | Viral-mediated gene transfer system |
| AU2894889A (en) | 1988-02-01 | 1989-08-03 | Monoclonetics International Incorporated | Genetic markers for down's syndrome, fetal abnormalities and twins |
| GB8911525D0 (en) | 1989-05-19 | 1989-07-05 | Allied Colloids Ltd | Polymeric composition |
| US5399346A (en) | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
| US5240846A (en) | 1989-08-22 | 1993-08-31 | The Regents Of The University Of Michigan | Gene therapy vector for cystic fibrosis |
| US5436146A (en) | 1989-09-07 | 1995-07-25 | The Trustees Of Princeton University | Helper-free stocks of recombinant adeno-associated virus vectors |
| DE69120146T2 (de) | 1990-01-12 | 1996-12-12 | Cell Genesys Inc | Erzeugung xenogener antikörper |
| US6150584A (en) | 1990-01-12 | 2000-11-21 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US5670488A (en) | 1992-12-03 | 1997-09-23 | Genzyme Corporation | Adenovirus vector for gene therapy |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| US5770429A (en) | 1990-08-29 | 1998-06-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5529774A (en) | 1991-08-13 | 1996-06-25 | The Regents Of The University Of California | In vivo transfer of the HSV-TK gene implanted retroviral producer cells |
| US5283185A (en) | 1991-08-28 | 1994-02-01 | University Of Tennessee Research Corporation | Method for delivering nucleic acids into cells |
| NZ244306A (en) | 1991-09-30 | 1995-07-26 | Boehringer Ingelheim Int | Composition for introducing nucleic acid complexes into eucaryotic cells, complex containing nucleic acid and endosomolytic agent, peptide with endosomolytic domain and nucleic acid binding domain and preparation |
| US5911983A (en) | 1992-06-26 | 1999-06-15 | University Of Pittsburgh | Gene therapy for Gaucher disease using retroviral vectors |
| US5843641A (en) * | 1993-02-26 | 1998-12-01 | Massachusetts Institute Of Technology | Methods for the daignosis, of familial amyotrophic lateral sclerosis |
| JP3626187B2 (ja) | 1993-06-07 | 2005-03-02 | バイカル インコーポレイテッド | 遺伝子治療に適するプラスミド |
| US5645829A (en) | 1993-06-18 | 1997-07-08 | Beth Israel Hospital Association | Mesothelial cell gene therapy |
| US5562909A (en) | 1993-07-12 | 1996-10-08 | Massachusetts Institute Of Technology | Phosphazene polyelectrolytes as immunoadjuvants |
| GB9326174D0 (en) | 1993-12-22 | 1994-02-23 | Biocine Sclavo | Mucosal adjuvant |
| US5656465A (en) | 1994-05-04 | 1997-08-12 | Therion Biologics Corporation | Methods of in vivo gene delivery |
| US5714353A (en) | 1994-05-24 | 1998-02-03 | Research Corporation Technologies, Inc. | Safe vectors for gene therapy |
| US20030072774A1 (en) | 1994-06-10 | 2003-04-17 | Diane M. Gajewczyk | Proteinaceous adjuvants |
| US5639642A (en) | 1994-06-16 | 1997-06-17 | Novo Nordisk A/S | Synthetic leader peptide sequences |
| DE19524720A1 (de) | 1995-07-12 | 1997-01-16 | Hoechst Ag | Zellspezifische Gentherapie mit Hilfe eines neuen Promotors für den "Tissue Inhibitor of Metalloproteinasn-3" |
| GB9506466D0 (en) | 1994-08-26 | 1995-05-17 | Prolifix Ltd | Cell cycle regulated repressor and dna element |
| US6019982A (en) | 1994-08-26 | 2000-02-01 | The Administrators Of The Tulane Educational Fund | Mutant enterotoxin effective as a non-toxic oral adjuvant |
| JP4216350B2 (ja) | 1994-09-19 | 2009-01-28 | 大日本住友製薬株式会社 | 動物細胞感染用の組換えｄｎａウイルスベクター |
| FR2726764B1 (fr) | 1994-11-14 | 1997-01-31 | Pasteur Merieux Serums Vacc | Adjuvant pour composition vaccinale |
| US5789147A (en) | 1994-12-05 | 1998-08-04 | New York Blood Center, Inc. | Method for concentrating white cells from whole blood by adding a red cell sedimentation reagent to whole anticoagulated blood |
| US5869040A (en) | 1995-06-07 | 1999-02-09 | Biogen, Inc | Gene therapy methods and compositions |
| US6743771B2 (en) | 1995-12-29 | 2004-06-01 | Novactyl, Inc. | Methods and compositions for controlling protein assembly or aggregation |
| US5834457A (en) * | 1996-01-26 | 1998-11-10 | The Regents Of The University Of California | Method of modulating radical formation by mutant cuznsod enzymes |
| US6270954B1 (en) * | 1996-04-10 | 2001-08-07 | The Regents Of The University Of California | Correction of genetic defects using chemical chaperones |
| US5735814A (en) | 1996-04-30 | 1998-04-07 | Medtronic, Inc. | Techniques of treating neurodegenerative disorders by brain infusion |
| US5928914A (en) | 1996-06-14 | 1999-07-27 | Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University | Methods and compositions for transforming cells |
| EP0861900A1 (en) * | 1997-02-21 | 1998-09-02 | Erziehungsdirektion Of The Canton Zurich | Immunological detection of prions |
| NZ333334A (en) | 1997-04-17 | 2001-06-29 | Frank L Sorgi | Delivery system for gene therapy to the brain |
| DE19742706B4 (de) | 1997-09-26 | 2013-07-25 | Pieris Proteolab Ag | Lipocalinmuteine |
| US7157098B1 (en) | 1998-01-06 | 2007-01-02 | Roman Perez-Soler | Gene therapy of tumors using non-viral delivery system |
| US6214565B1 (en) | 1998-10-09 | 2001-04-10 | The Regents Of The University Of California | Assay for disease related conformation of a protein and isolating same |
| WO1999061066A2 (en) | 1998-05-27 | 1999-12-02 | Avigen, Inc. | Convection-enhanced delivery of aav vectors |
| GB9818756D0 (en) | 1998-08-27 | 1998-10-21 | Microbiological Research Agenc | Superoxide dismutase as a vaccine antigen |
| EP1121429A2 (en) | 1998-10-16 | 2001-08-08 | Introgene B.V. | Gene therapy of alzheimer's disease by delivery of an encoded apolipoprotein e |
| US7012061B1 (en) | 1998-10-19 | 2006-03-14 | New York University | Method for increasing the permeability of the blood brain barrier |
| US7041807B1 (en) * | 1999-06-23 | 2006-05-09 | Caprion Pharmaceuticals, Inc. | Antibodies to a YYX epitope of a mammalian prion protein |
| NZ516240A (en) | 1999-06-23 | 2005-11-25 | Caprion Pharmaceuticals Inc | Prion protein peptides and uses thereof |
| EP1204674A4 (en) | 1999-07-27 | 2005-06-01 | Abgenix Inc | METHODS AND COMPOUNDS FOR PREVENTING POLYPEPTIDE COLLECTIONS ASSOCIATED WITH NEUROLOGICAL DISORDERS |
| EP1132098B1 (en) | 1999-09-21 | 2010-05-26 | AnGes MG, Inc. | Gene therapy for cerebrovascular disorders |
| SI1354204T2 (sl) | 2000-06-15 | 2010-09-30 | Novartis Vaccines & Diagnostic | Hcv antigen antitelo kombinacijska analiza |
| WO2002053191A1 (en) | 2001-01-05 | 2002-07-11 | Viromed Limited | Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof |
| AU2002310497A1 (en) * | 2001-06-20 | 2003-01-08 | Caprion Pharmaceuticals Inc. | Protein aggregation assays and uses thereof |
| DE10152677A1 (de) | 2001-10-19 | 2003-05-08 | Aventis Behring Gmbh | Antikörper zum spezifischen Nachweis von pathogenen Prionen humanen Ursprungs und damit durchgeführten Nachweisverfahren |
| AU2002349583B2 (en) | 2001-11-28 | 2007-11-22 | Anges Mg, Inc. | Genetic remedies for neurodegenerative diseases |
| US7141044B2 (en) | 2001-12-11 | 2006-11-28 | Ekos Corporation | Alternate site gene therapy |
| AU2002950217A0 (en) | 2002-07-16 | 2002-09-12 | Prana Biotechnology Limited | 8- Hydroxy Quinoline Derivatives |
| ATE506072T1 (de) * | 2002-09-12 | 2011-05-15 | Univ California | Immunogene und entsprechende antikörper, die spezifisch sind für häufige hochmolekulare aggregations-zwischenprodukte von amyloiden aus proteinen unterschiedlicher sequenz |
| AU2003266801B2 (en) | 2002-12-19 | 2010-02-25 | Ortho-Clinical Diagnostics, Inc | Detection and diagnosis of transmissable spongiform encephalopathies |
| EP1615557B1 (en) | 2003-04-15 | 2012-09-19 | Philips Intellectual Property & Standards GmbH | Method and apparatus for improved determination of spatial non-agglomerated magnetic particle distribution in an area of examination |
| EP1668369B1 (en) | 2003-08-20 | 2016-01-06 | ProMIS Neurosciences Inc. | Epitope protection assay and method for detecting protein conformations |
| CA2536305C (en) | 2003-08-20 | 2015-10-27 | Amorfix Life Sciences Ltd. | Sod-1 epitopes and antibodies |
| CA2437675A1 (en) | 2003-08-20 | 2005-02-20 | Neil Cashman | Methods of detecting prion protein |
| CA2437999C (en) | 2003-08-20 | 2013-10-08 | Neil Cashman | Epitope protection assay |
| WO2005024042A2 (en) | 2003-09-04 | 2005-03-17 | The Regents Of The University Of California | Aptamers and methods for their in vitro selection and uses thereof |
| WO2005077040A2 (en) | 2004-02-11 | 2005-08-25 | Rensselaer Polytechnic Institute | Compositions and methods for treating amyotrophic lateral sclerosis (als) |
| US20060073119A1 (en) | 2004-09-01 | 2006-04-06 | Avigen, Inc. | Methods for treating neurodegenerative disorders |
| US20060122116A1 (en) | 2004-11-03 | 2006-06-08 | The Johns Hopkins University | Treatment for disorders of the peripheral nervous system |
| US20060129126A1 (en) | 2004-11-19 | 2006-06-15 | Kaplitt Michael G | Infusion device and method for infusing material into the brain of a patient |
| US20060211079A1 (en) * | 2005-02-18 | 2006-09-21 | Hazen Stanley L | Systemic markers for asthma and analogous diseases |
| US20060194821A1 (en) | 2005-02-18 | 2006-08-31 | The Brigham And Women's Hospital, Inc. | Compounds inhibiting the aggregation of superoxide dismutase-1 |
| CA2620351C (en) * | 2005-08-31 | 2015-04-21 | Universite Laval | Antibodies and their use in the treatment, prevention and diagnosis of a disease associated with sod1 abnormalities |
| US7887803B2 (en) * | 2005-12-02 | 2011-02-15 | Amorfix Life Sciences | Methods and compositions to treat misfolded-SOD1 mediated diseases |
| US7794692B2 (en) | 2005-12-02 | 2010-09-14 | Amorfix Life Sciences Ltd. | Methods and compositions for detecting amyotrophic lateral sclerosis |
| US7977314B2 (en) | 2005-12-02 | 2011-07-12 | Amorfix Life Sciences Limited | Methods and compositions to treat and detect misfolded-SOD1 mediated diseases |
| US20070202537A1 (en) | 2005-12-05 | 2007-08-30 | Prosetta Corporation | Biomarkers for als |
| CN201029168Y (zh) | 2007-03-09 | 2008-02-27 | 富士康(昆山)电脑接插件有限公司 | 电连接器 |
| JP4701420B2 (ja) | 2007-07-31 | 2011-06-15 | タイヨーエレック株式会社 | 弾球遊技機 |
| WO2010003227A1 (en) | 2008-07-08 | 2010-01-14 | Amorfix Life Sciences Ltd. | Detection of protein aggregates |
| FR2933686B1 (fr) | 2008-07-09 | 2010-11-19 | Saint Gobain Emballage | Composition de renforcement du verre creux et de protection de celui-ci contre la rayure, procedes de traitement correspondants et verre creux traite obtenu |
| AU2009301580B2 (en) | 2008-10-06 | 2015-11-26 | The University Of British Columbia | Methods and systems for predicting misfolded protein epitopes |
| JP2010153006A (ja) | 2008-12-26 | 2010-07-08 | Konica Minolta Opto Inc | 対物光学素子及び光ピックアップ装置 |
| CA2753621A1 (en) | 2009-03-02 | 2010-09-10 | The University Of British Columbia | Antibodies and epitopes specific to misfolded prion protein |
| CA3233345A1 (en) | 2012-04-09 | 2013-10-17 | Case Western Reserve University | Compositions and methods for inhibiting the activity of lar family phosphatases |
| CA2877505C (en) | 2012-06-12 | 2020-09-22 | Helix Biopharma Corp. | Antibodies and conjugates that target misfolded prion protein |
| US9902442B2 (en) | 2015-04-06 | 2018-02-27 | John P. Moyna | Track link |
-
2007
- 2007-03-05 US US11/682,217 patent/US7977314B2/en active Active
- 2007-03-05 CA CA2642848A patent/CA2642848C/en active Active
- 2007-03-05 WO PCT/CA2007/000346 patent/WO2007098607A1/en not_active Ceased
- 2007-03-05 AU AU2007219615A patent/AU2007219615B2/en not_active Ceased
- 2007-03-05 EP EP07710682.1A patent/EP1989308B1/en not_active Not-in-force
- 2007-03-05 EP EP12161568A patent/EP2514824A3/en not_active Withdrawn
- 2007-03-05 EP EP12161575.1A patent/EP2495327B1/en not_active Not-in-force
- 2007-03-05 DK DK12161575.1T patent/DK2495327T3/da active
- 2007-03-05 JP JP2008556626A patent/JP5823663B2/ja not_active Expired - Fee Related
- 2007-03-05 EP EP12161564.5A patent/EP2514823B1/en not_active Not-in-force
- 2007-03-05 EP EP12161571A patent/EP2502999A3/en not_active Withdrawn
- 2007-03-05 DK DK12161564.5T patent/DK2514823T3/en active
-
2011
- 2011-06-08 US US13/155,939 patent/US8778885B2/en not_active Expired - Fee Related
-
2014
- 2014-06-10 US US14/300,858 patent/US9637552B2/en not_active Expired - Fee Related
-
2017
- 2017-03-31 US US15/476,440 patent/US20180079825A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009529498A5 (https=) | ||
| US10208111B2 (en) | Alpha-synuclein antibodies and uses thereof | |
| AU2011282476B2 (en) | Anti-IL-23 heterodimer specific antibodies | |
| CN102596997B (zh) | 特异性结合Aβ寡聚体的抗体及其用途 | |
| HRP20171292T1 (hr) | Polipeptidi i konjugati klorotoksina i njihove uporabe | |
| CN113891746B (zh) | 焦谷氨酸淀粉样蛋白-β的抗体及其用途 | |
| CN102574915A (zh) | 特异性结合Aβ寡聚体的抗体及其用途 | |
| CN102459335A (zh) | 特异性结合Aβ寡聚体的抗体及其用途 | |
| JP2020534830A5 (https=) | ||
| CN114667296B (zh) | 一种双特异性抗体及其用途 | |
| EP2170940B1 (en) | New bnp(1-32) epitope and antibodies directed against said epitope | |
| JP7829171B2 (ja) | ミスフォールドｔｄｐ－４３に対する抗体およびその使用方法 | |
| JP2011501946A5 (https=) | ||
| US20210347868A1 (en) | Anti-synuclein antibodies | |
| JP2017524362A5 (https=) | ||
| JP6316746B2 (ja) | 多発性硬化症の診断および治療のための手段および方法 | |
| RU2016137807A (ru) | Новое антитело против пресепсина | |
| CA2772180A1 (en) | Anti-npy and pyy antibodies and uses thereof | |
| CN114702585B (zh) | 一种抗cd22的单克隆抗体4f6及其制备方法和用途 | |
| JP7564882B2 (ja) | Ａｒｅｇに対する抗体及びその用途 | |
| WO2026046978A1 (en) | Anti-adm antibodies, anti-adm antibody fragment or anti-adm non-ig scaffold for therapy or prevention of immune effector cell therapy side effects | |
| WO2025217579A1 (en) | Anti-hsa vhh antibodies and compositions thereof | |
| KR20260044274A (ko) | Tdp-43에 특이적으로 결합하는 항체 및 이의 용도 | |
| WO2025232057A1 (zh) | 可结合人cd137单克隆抗体或其功能性片段及其应用 | |
| HK40070151B (en) | Bispecific antibody and use thereof |